← Back to Search

Non-invasive Brain Stimulation

20 Hz rTMS for Schizophrenia (rTMS-FPCC Trial)

N/A
Waitlist Available
Led By Tom Hummer, PhD
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day
Awards & highlights

rTMS-FPCC Trial Summary

This trial will test the effects of a new treatment for psychosis on the brain.

rTMS-FPCC Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in BOLD Signal in Anterior Cingulate Cortex
Change in Cognitive Control Network Functional Connectivity

rTMS-FPCC Trial Design

2Treatment groups
Experimental Treatment
Group I: 20 Hz rTMS targeting the LDLPFC first, then 20 Hz rTMS targeting the LSPCExperimental Treatment1 Intervention
Group II: 20 Hz rTMS Targeting the LSPC first, then 20 Hz rTMS Targeting the LDLPFCExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
20 Hz rTMS
2020
N/A
~20

Find a Location

Who is running the clinical trial?

Indiana UniversityLead Sponsor
993 Previous Clinical Trials
1,095,275 Total Patients Enrolled
14 Trials studying Schizophrenia
1,003 Patients Enrolled for Schizophrenia
Tom Hummer, PhDPrincipal InvestigatorIndiana University
Michael M Francis, MDPrincipal InvestigatorIndiana University
~3 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top